Print  |  Close

Pearlman Cancer Center at South Georgia Medical Center

The Pearlman Comprehensive Cancer Center at South Georgia Medical Center (SGMC) is a cancer center located in Valdosta, Georgia. The center is accredited by the American College of Surgeons Commission on Cancer as a Community Hospital Comprehensive Cancer Program. The center is also accredited by the American College of Radiology (ACR). There are five physicians at the center. The Radiation Oncology program at SGMC is one of seven in Georgia accredited by the American College of Radiology. The center offers stereotactic radiotherapy, clinical trials, cancer survivorship program, prevention, nutrition, screening recommendations and treatment. Pearlman Cancer Center's comprehensive, multidisciplinary approach to care that includes the medical, nutritional, spiritual, educational and psychosocial needs of patients.

Treatment Sites in Georgia

Primary Location

2501 North Patterson Street
Valdosta, GA 31602
229-259-4600 (p)
www.sgmc.org

driving directions

Clinical Trials in Georgia

An Observational Research Study for Cancer Patients on Immune Checkpoint Inhibitors, DiRECT Study
Cancer Type: Hematopoietic Malignancies, Solid Tumor

An Observational Research Study to Uncover Subtypes of Cancer Cachexia, LOTUS-CC Study
Cancer Type: Colon/Rectal Cancer, Lung Cancer

Genetic Testing in Screening Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Cancer Type: Lung Cancer, Unknown Primary

Mobile Health for Adherence in Breast Cancer Patients
Cancer Type: Breast Cancer

Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study
Cancer Type: Breast Cancer, Unknown Primary

Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
Cancer Type: Multiple Myeloma

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early Triple Negative Breast Cancer
Cancer Type: Breast Cancer, Unknown Primary

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/NSABP B-63)
Cancer Type: Breast Cancer

Testing Immunotherapy versus Observation in Patients with HPV Throat Cancer
Cancer Type: Head and Neck Cancer, Unknown Primary

Testing the Addition of Chemotherapy to the Usual Treatment of Ovarian Function Suppression plus Hormonal Therapy in Premenopausal ER-Positive/HER2-Negative Breast Cancer Patients Who Are At High Risk of Cancer Returning, OFSET Trial
Cancer Type: Breast Cancer, Unknown Primary

Testing the Addition of Daratumumab-Hyaluronidase to Enhance Therapeutic Effectiveness of Lenalidomide in Smoldering Multiple Myeloma, The DETER-SMM Trial
Cancer Type: Multiple Myeloma

Testing the Usual Treatment of Radiation Therapy and HER2-Targeted Therapy to HER2-Targeted Therapy Alone for Low-Risk HER2-Positive Breast Cancer, The HERO Trial
Cancer Type: Breast Cancer
**GeorgiaCancerInfo is not a medical practice. This is an informational web site provided by Georgia CORE, a nonprofit striving to provide current and comprehensive information on cancer care in Georgia through this website. If you find erroneous or missing information, please contact us.